Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03133650 · ClinicalTrials.gov registry record · Phase 1

A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing

A Phase 1 study of Esophagogastric Cancer and Moderate to Severe Dysphagia, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
Phase 1
Development phase
12
Enrollment target
3
Study locations

NCT03133650 is a Phase 1 study of Esophagogastric Cancer and Moderate to Severe Dysphagia that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 12 participants, below the 81-participant average among 5 other Esophagogastric Cancer trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03133650, a Phase 1 study of Esophagogastric Cancer and Moderate to Severe Dysphagia, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
12 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to establish the highest dose of laser light for WST-11 VTP to treat obstruction from esophageal cancer that can be safely given.

Conditions Studied

Esophagogastric Cancer Moderate to Severe Dysphagia

Interventions

  • DRUG WST 11-mediated VTP therapy

Study Locations (3)

New York

  • Memorial Sloan - Kettering Cancer Center - New York
  • Weill Cornell Medical Center (Data Analysis Only) - New York

Other

  • Weizmann Institute of Science - Rehovot

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2017-04-26
Est. Completion 2026-02-23
Phase Phase 1

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03133650

The ClinicalTrials.gov registry entry for NCT03133650 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 5 other Esophagogastric Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Esophagogastric Cancer appearing as the primary indexed condition, and to 1 intervention - of which WST 11-mediated VTP therapy is the first listed.

NCT03133650 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Other.

Frequently Asked Questions

What is clinical trial NCT03133650 about?

NCT03133650 is a clinical study titled "A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing". The purpose of this study is to establish the highest dose of laser light for WST-11 VTP to treat obstruction from esophageal cancer that can be safely given.

What is the current status of trial NCT03133650?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2017-04-26. Estimated completion is 2026-02-23.

What conditions does trial NCT03133650 study?

This clinical trial studies the following conditions: Esophagogastric Cancer, Moderate to Severe Dysphagia.

What interventions are being tested in trial NCT03133650?

The interventions under investigation include: WST 11-mediated VTP therapy (DRUG).

Who is sponsoring clinical trial NCT03133650?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03133650 being conducted?

This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Esophagogastric Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Esophagogastric Cancer

All registered trials for this condition

Moderate to Severe Dysphagia

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.